All Stories

  1. Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study
  2. Efficacy of localized hand and foot phototherapy: a review of patients treated in a teaching hospital setting
  3. Are photosensitizing medications associated with increased risk of important erythemal reactions during ultraviolet B phototherapy?
  4. Narrowband ultraviolet B treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments
  5. The widespread use of topical antimicrobials enriches for resistance in Staphylococcus aureus isolated from patients with atopic dermatitis
  6. Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythema dose
  7. An overview of the cutaneous porphyrias
  8. Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate
  9. Mild classical xeroderma pigmentosum
  10. Freely available meteorological data can be used to predict population vitamin D levels
  11. Interventions for the pain of topical photodynamic therapy
  12. A new way of targeting phototherapy to body sites where it is needed
  13. Topical sunscreens and vitamin D
  14. Alopecia Areata
  15. Induction of tolerance in solar urticaria by ultraviolet A ‘rush hardening’: is this true desensitization?
  16. Ultraviolet A1 phototherapy: a British Photodermatology Group workshop report
  17. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy
  18. Reduced dermatology hospital bed numbers in Scotland: where do patients go?
  19. Proteinuria with fumaric acid ester treatment for psoriasis
  20. Bath psoralen plus ultraviolet A for hidradenitis suppurativa: a review of 13 patients
  21. A review of pain experienced during topical photodynamic therapy—Our experience in Dundee
  22. A Randomized Comparison of Methods of Selecting Narrowband UV-B Starting Dose to Treat Chronic Psoriasis
  23. Randomized Double-blind Comparative Study of 8-Methoxypsoralen Bath Plus UV-A Treatment Regimens
  24. Photopatch testing negative in systemic quinine phototoxicity
  25. There are no ‘safe exposure limits’ for phototherapy
  26. False-negative monochromator phototesting in chronic actinic dermatitis
  27. Comparing narrowband ultraviolet B treatment regimens for psoriasis
  28. Using ‘number needed to treat’ to express the magnitudes of benefit of ultraviolet B phototherapy and of antitumour necrosis factor-α therapies for psoriasis
  29. Randomized Comparison of Mohs Micrographic Surgery and Surgical Excision for Small Nodular Basal Cell Carcinoma
  30. Reactivity to autologous serum skin test and relationship with complement levels in chronic idiopathic urticaria and angio-oedema
  31. Presentation of leishmaniasis (Leishmania infantum) in the skin of a patient with severe atopic dermatitis
  32. Narrowband UVB phototherapy
  33. Delayed ultraviolet erythema not suppressed by oral prednisolone: a randomized crossover study
  34. A double-blind, randomized assessment of the irritant potential of sunscreen chemical dilutions used in photopatch testing
  35. Time course for development of psoralen plus ultraviolet A erythema following oral administration of 5-methoxypsoralen
  36. Prevalences of chronic photodermatoses in Scotland
  37. Population reference intervals for minimal erythemal doses in monochromator phototesting
  38. Dermatomyositis presenting with symptomatic dermographism and raised troponin T: a case report
  39. Occupational carprofen photoallergic contact dermatitis
  40. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy
  41. A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma
  42. Within-patient right-left blinded comparison of diode (810 nm) laser therapy and intense pulsed light therapy for hair removal
  43. A randomized study of minimal curettage followed by topical photodynamic therapy compared with surgical excision for low-risk nodular basal cell carcinoma
  44. Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo
  45. UVA1 phototherapy for genital lichen sclerosus
  46. UVA1 phototherapy for treatment of necrobiosis lipoidica
  47. Dose-Response and Time-Course Characteristics of UV-A1 Erythema
  48. Does narrow-band ultraviolet B phototherapy work in atopic dermatitis through a local or a systemic effect?
  49. Can St John's wort (hypericin) ingestion enhance the erythemal response during high-dose ultraviolet A1 therapy?
  50. A randomised, blinded, controlled study of the clinical relevance of matching pulse duration to thermal relaxation time when treating facial telangiectasia
  51. A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis
  52. A positive correlation between history of psoriasis response to sunlight and the response to UVB phototherapy. What are the consequences?
  53. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data
  54. Chronic actinic dermatitis recognized on minimal erythema dose testing prior to narrow-band UVB treatment for psoriasis
  55. Knowledge of Body Site Variability in Ultraviolet-Induced Erythemal Responses Guides Choice of Site for Pre-Therapy Minimal Erythema Dose Testing
  56. Chronic Actinic Dermatitis in the Elderly
  57. Dermatoscopic features of benign sebaceous proliferation
  58. Can a positive photopatch test be elicited by subclinical irritancy or allergy plus suberythemal UV exposure?
  59. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy
  60. Co-existence of chronic actinic dermatitis and solar urticaria in three patients
  61. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report
  62. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen
  63. History of psoriasis response to sunlight does not predict outcome of UVB phototherapy
  64. The characteristics of erythema induced by topical 5-aminolaevulinic acid photodynamic therapy
  65. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (AmetopR) for pain relief during topical photodynamic therapy
  66. Narrow-band (TL-01) ultraviolet B phototherapy for chronic urticaria
  67. Environmental effects and skin disease
  68. A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity
  69. Characteristics and Prognosis of Idiopathic Solar Urticaria
  70. A quantitative review of studies comparing the efficacy of narrow-band and broad-band ultraviolet B for psoriasis
  71. Quantitative Real-Time Reverse Transcription–Polymerase Chain Reaction Analysis of Drug Metabolizing and Cytoprotective Genes in Psoriasis and Regulation by Ultraviolet Radiation
  72. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5?, 8-trimethylpsoralen
  73. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources
  74. A randomized controlled trial of narrowband ultraviolet B vs. bath-psoralen plus ultraviolet A photochemotherapy for psoriasis
  75. Allergic contact dermatitis in venous leg ulcer patients
  76. Ultraviolet A1 phototherapy
  77. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases
  78. The Time Course of Topical PUVA Erythema Following 15- and 5-Minute Methoxsalen Immersion
  79. Diagnosis and treatment of chronic actinic dermatitis
  80. An Intraindividual Study of the Characteristics of Erythema Induced by Bath and Oral Methoxsalen Photochemotherapy and Narrowband Ultraviolet B¶
  81. Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service
  82. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis
  83. A laser-clinic nurse with allergic contact dermatitis from tetracaine
  84. New sunscreens confer improved protection for photosensitive patients in the blue light region
  85. The Effect of Methoxsalen Dose on Ultraviolet-A-Induced Erythema
  86. Photosensitizing drugs may lower the narrow-band ultraviolet B (TL-01) minimal erythema dose
  87. Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group
  88. Porphyria cutanea tarda presenting as solar urticaria
  89. Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen?
  90. Pigmented Papules and Weight Loss
  91. Narrow‐band (TL‐01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment?
  92. Multiple widespread eruptive Spitz naevi
  93. PUVA for diffuse cutaneous reticulohistiocytosis
  94. The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients
  95. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin
  96. Daisy, dandelion and thistle contact allergy in the photosensitivity dermatitis and actinic reticuloid syndrome